Impact of respiratory virus molecular testing on antibiotic utilization in community-acquired pneumonia

    loading  Checking for direct PDF access through Ovid

Abstract

We compared the clinical characteristics and antibiotic therapy of community-acquired pneumonia patients who were positive on a respiratory virus molecular test (polymerase chain reaction) with those who were negative. We found that respiratory virus molecular polymerase chain reaction testing has a minimal impact on reducing antibiotic utilization among viral pneumonia patients.

Related Topics

    loading  Loading Related Articles